NASDAQ:AMGN
Amgen Inc.
Amgen Inc.'s revenue grew 10.0% in fiscal 2025 to $36.8B while operating margin rose to 24.7%. Free cash flow was $8.1B, 22.0% of revenue.Summary generated from Amgen Inc.'s SEC filings. Latest annual report filed Feb 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$36.8B
Revenue growth+10.0%
Revenue, 5-yr CAGR+7.6%
Gross margin67.2%
Operating margin24.7%
Net margin21.0%
ROIC14.4%
Return on equity106.1%
Debt / equity6.31
Free cash flow$8.1B
FCF margin22.0%
Share count change+0.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 26.0 | 26.3 | 28.2 | 33.4 | 36.8 |
| Operating income | 7.6 | 9.6 | 7.9 | 7.3 | 9.1 |
| Net income | 5.9 | 6.6 | 6.7 | 4.1 | 7.7 |
| Free cash flow | 8.4 | 8.8 | 7.4 | 10.4 | 8.1 |
Recent filings
- 4Insider transaction report
Aug 13, 2026 - 4Insider transaction report
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KCurrent report
Jul 31, 2026 - 8-KResults of a shareholder vote
May 20, 2026 - 8-KDirector or officer change
May 19, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 1, 2026